Hyperbaric oxygen treatment and pulmonary air-containing lesions.

IF 1.3 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Diving and hyperbaric medicine Pub Date : 2025-12-20 DOI:10.28920/dhm55.4.343-351

Osman Türkmen, Recep Özkan, Kübra Özgök Kangal, Merve Dur İnce, Yakup Arslan

{"title":"Hyperbaric oxygen treatment and pulmonary air-containing lesions.","authors":"Osman Türkmen, Recep Özkan, Kübra Özgök Kangal, Merve Dur İnce, Yakup Arslan","doi":"10.28920/dhm55.4.343-351","DOIUrl":null,"url":null,"abstract":"Introduction: Pulmonary barotrauma is a rare but serious complication of hyperbaric oxygen treatment. Pulmonary air-containing lesions may predispose pulmonary barotrauma by causing air trapping during changes in environmental pressure. This study aimed to investigate whether pulmonary air-containing lesions cause pulmonary barotrauma during hyperbaric oxygen treatment.Methods: This study retrospectively analysed data from individuals who presented to the Undersea and Hyperbaric Medicine Clinic at Gülhane Training and Research Hospital, Health Sciences University, between 2017 and 2022. The relationship between presence of pulmonary air-containing lesions on computed tomography and pulmonary barotrauma was evaluated.Results: Gas containing lesions were not associated with an increased risk of pulmonary barotrauma. The incidence of pneumothorax during hyperbaric oxygen was extremely low (0.0059% per session, 0.15% per patient).Conclusions: Pulmonary air-containing lesions, including bullae, were not associated with an increased risk under standard hyperbaric oxygen treatment protocols. Routine chest computed tomography screening is not warranted due to the low complication rate. Nevertheless, clinical evaluation and informed consent are essential, particularly for patients with underlying lung disease. Further studies are needed to improve risk assessment.","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 4","pages":"343-351"},"PeriodicalIF":1.3000,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13092556/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diving and hyperbaric medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.28920/dhm55.4.343-351","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Pulmonary barotrauma is a rare but serious complication of hyperbaric oxygen treatment. Pulmonary air-containing lesions may predispose pulmonary barotrauma by causing air trapping during changes in environmental pressure. This study aimed to investigate whether pulmonary air-containing lesions cause pulmonary barotrauma during hyperbaric oxygen treatment.

Methods: This study retrospectively analysed data from individuals who presented to the Undersea and Hyperbaric Medicine Clinic at Gülhane Training and Research Hospital, Health Sciences University, between 2017 and 2022. The relationship between presence of pulmonary air-containing lesions on computed tomography and pulmonary barotrauma was evaluated.

Results: Gas containing lesions were not associated with an increased risk of pulmonary barotrauma. The incidence of pneumothorax during hyperbaric oxygen was extremely low (0.0059% per session, 0.15% per patient).

Conclusions: Pulmonary air-containing lesions, including bullae, were not associated with an increased risk under standard hyperbaric oxygen treatment protocols. Routine chest computed tomography screening is not warranted due to the low complication rate. Nevertheless, clinical evaluation and informed consent are essential, particularly for patients with underlying lung disease. Further studies are needed to improve risk assessment.

查看原文本刊更多论文

高压氧治疗和肺含气病变。

肺气压损伤是高压氧治疗中一种罕见但严重的并发症。在环境压力变化时，肺部含气病变可引起空气滞留，从而使肺部气压损伤易感。本研究旨在探讨在高压氧治疗期间肺含气病变是否引起肺气压损伤。方法：本研究回顾性分析了2017年至2022年间在健康科学大学g lhane培训与研究医院海底和高压医学诊所就诊的患者的数据。评估了计算机断层扫描中肺部含气病变与肺气压损伤之间的关系。结果：含气体的病变与肺气压损伤的风险增加无关。高压氧治疗期间气胸的发生率极低（0.0059% /次，0.15% /例）。结论：在标准高压氧治疗方案下，肺含气病变（包括肺大泡）与风险增加无关。由于并发症发生率低，不需要常规胸部计算机断层扫描。然而，临床评估和知情同意是必不可少的，特别是对于有潜在肺部疾病的患者。需要进一步的研究来改进风险评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diving and hyperbaric medicine 医学-公共卫生、环境卫生与职业卫生

CiteScore

1.70

自引率

22.20%

发文量

审稿时长

>12 weeks

期刊介绍： Diving and Hyperbaric Medicine (DHM) is the combined journal of the South Pacific Underwater Medicine Society (SPUMS) and the European Underwater and Baromedical Society (EUBS). It seeks to publish papers of high quality on all aspects of diving and hyperbaric medicine of interest to diving medical professionals, physicians of all specialties, scientists, members of the diving and hyperbaric industries, and divers. Manuscripts must be offered exclusively to Diving and Hyperbaric Medicine, unless clearly authenticated copyright exemption accompaniesthe manuscript. All manuscripts will be subject to peer review. Accepted contributions will also be subject to editing.